SYNCONA - Key Persons


Abbey Webb

Job Titles:
  • Executive Assistant
  • Executive Assistant of Syncona Investment Management Ltd
Abbey is Executive Assistant of Syncona Investment Management Ltd. supporting a number of the partners, assisting with events and other operational functions. Prior to joining Syncona, Abbey was Manager at Clues & Co. a digital forensic and Expert Witness consultancy and she has also held music industry related roles.

Alex Hamilton

Job Titles:
  • Partner of Syncona Investment Management Ltd
Alex is a Partner of Syncona Investment Management Ltd. Previously, he was a member of the Healthcare Investment Banking team at Jefferies, where he worked on a range of financings and mergers and acquisitions across the biotechnology, pharmaceutical and healthcare sectors. Alex has a PhD in Immunology from the University of Cambridge.

Alice Renard

Job Titles:
  • Partner of Syncona Investment Management Ltd
Alice is a Partner of Syncona Investment Management Ltd. Prior to joining Syncona, Alice was an Investment Banking Analyst within Barclays' Healthcare Corporate Finance and M&A team, where she worked on transactions involving pharmaceutical and other healthcare companies. Prior to Barclays, Alice worked briefly at AbbVie and Janssen. Alice holds a Doctorate degree in Pharmacy from the University of Lille 2 (School of Pharmacy, Lille, France). She holds a Masters in International Health Policy & Health Economics from the London School of Economics (London, UK).

Amisha Choksi

Job Titles:
  • Management Accountant
Amisha is a Management Accountant at Syncona Investment Management limited Amisha has over a decade of Accounting experience with focuses in Marketing and Advertising industries. Her educational background includes a Masters degree in Commerce from Gujarat University, India and she is on route to completing her ACCA Chartership.

Andrew Cossar - Chief Legal Officer

Job Titles:
  • General Counsel
Andrew is the General Counsel of Syncona Investment Management Ltd. Previously, he was Chief Investment Counsel at the Wellcome Trust, responsible for legal issues arising from its £23bn global multi-asset investment portfolio, and where he was involved in the initial formation of Syncona Partners LLP. Prior to that he worked as a corporate lawyer in London and Edinburgh. Andrew has an LLB from the University of Glasgow.

Annabel Clay

Job Titles:
  • Investor Relations and Communications Manager
Annabel is Investor Relations and Communications Manager at Syncona Investment Management Ltd Previously, she was a Consultant at Greenbrook Communications, advising clients on a wide range of projects and transactions. Prior to that, Annabel spent several years at a leading financial communications firm, where she worked with companies across a number of sectors. She has an Honours Degree in History from the University of Bristol.

Caroline Horsford

Job Titles:
  • Executive Assistant
Caroline is an Executive Assistant at Syncona Investment Management Limited supporting the Senior Management Team and the Board. Prior to joining Syncona, Caroline held senior support roles in a number of sectors, most recently at Odgers Berndtson where she supported the Global Head of Marketing and Head of Research. Caroline holds a degree in Hispanic Studies and History from the University of Nottingham.

Chris Hollowood - Chief Investment Officer

Job Titles:
  • Chief Investment Officer
  • Member of the Syncona Team
Chris is the Chief Investment Officer of Syncona Investment Management Ltd. He is currently Chairman at five Syncona companies: NightStar Therapeutics (NASDAQ:NITE), Freeline Therapeutics, Gyroscope Therapeutics, Swan Therapeutics and Orbit Biomedical. He has been instrumental in their foundation and development including the acquisition of a gene therapy manufacturing platform from Rentschler Biotechnologie on behalf of Freeline. Previously, he was a partner of Apposite Capital LLP, a venture and growth capital healthcare investment company. Before Apposite, Chris had roles with Bioscience Managers Ltd, Neptune Investment Management Ltd and in the pharmaceutical industry. Chris holds a degree in Natural Sciences and a PhD in Organic Chemistry, both from the University of Cambridge.

Clare Terlouw

Job Titles:
  • Head of Corporate Development
Clare is Head of Corporate Development at Syncona Investment Management Ltd. Clare has 15 years' experience as a specialist healthcare and life sciences corporate financier in London. Clare joined Syncona from Numis Securities, where she was a Managing Director, Healthcare & Life Sciences, Corporate Advisory and Broking. She focused on advising LSE Main Market and AIM listed healthcare and life sciences companies and has extensive experience across a range of financing and M&A transactions for growing, innovative healthcare companies. Clare was previously at Nomura Code and Peel Hunt, and was an orthopaedic physiotherapist treating patients for acute sport and trauma injuries.

David Twumasi

Job Titles:
  • Accountant
David Twumasi is an Accountant at Syncona Investment Management Limited. He has previously worked in Media and judiciary Service companies covering similar areas of work. He has a science background through his BSc in Biomedical Science from the University of Kent and has since gained a degree in Accounting as he works towards his ACCA Chartership.

Dominic Schmidt

Job Titles:
  • Partner of Syncona Investment Management Ltd
Dominic is a Partner of Syncona Investment Management Ltd. Prior to joining Syncona, he worked for strategy consultancy L.E.K. Consulting. Dominic received his PhD from the Department of Oncology at the University of Cambridge, where he was a Cancer Research UK scholar. He also holds a German Diplom Degree in Biochemistry and his research has been honoured with national and international prizes and published in Cell, Nature and Science.

Edward Hodgkin

Job Titles:
  • Partner
  • Partner of Syncona Investment Management Ltd
Edward Hodgkin is a Partner of Syncona Investment Management Ltd. He is currently Executive Chairman of Syncona's company OMass Therapeutics, and was previously the first CEO and a board member of Autolus Therapeutics (NASDAQ:AUTL). Within the Syncona life science team, he is involved in creation of new businesses and then fills executive roles within those companies to make them operational. Prior to Syncona, he was CEO of Biotica Ltd (Cambridge, UK), President & Chief Business Officer of BrainCells Inc (San Diego, CA), and VP, Business Development & Marketing at Tripos Inc (St Louis, MO). Ed's early career was spent in research and management positions with Wyeth-Ayerst Inc and British Biotech. He holds a degree and DPhil in Chemistry from the University of Oxford, and is a former Chairman of the BIA, the UK's trade association for innovative life science companies.

Elisa Petris

Job Titles:
  • Partner of Syncona Investment Management Ltd
Elisa is a Partner of Syncona Investment Management Ltd. She is a Director on the Board of Blue Earth Diagnostics, Achilles Therapeutics and Quell Therapeutics. She was closely involved in the foundation of these companies, including their operational and strategic set-up. Previously, she was a Senior Associate at Michel Dyens & Co. working on transactions covering the healthcare space, and a member of the Life Science team at L.E.K. Consulting based in London. While at L.E.K. she worked on projects for biotech, pharma and private equity clients. Elisa has a PhD in Molecular Biology from Imperial College and an MBA from London Business School.

Ellen Strahlman

Job Titles:
  • Non - Executive Director
  • Senior Executive
  • Executive Vice President, Research & Development and Chief Medical Officer for BD
Ellen Strahlman recently retired as the Executive Vice President, Research & Development and Chief Medical Officer for BD (Becton, Dickinson and Company), a leading global medical technology company, a role she held since 2013. Prior to this, she served as the Senior Vice President and Chief Medical Officer (‘CMO') at GlaxoSmithKline, as well as senior executive leadership roles in leading pharmaceutical and medical technology companies including Pfizer, Novartis, Bausch & Lomb and Merck. Experience Ellen is a senior executive with over 25 years of experience in global product development and commercialisation in a wide range of areas such as biopharmaceuticals, medical devices, vaccines, consumer products and international health. She is a graduate of Harvard University (Biochemical Sciences); obtained her medical degree from the Johns Hopkins School of Medicine; and earned a Master's Degree in Health Sciences from the Johns Hopkins Bloomberg School of Public Health as a CarnegieMellon Physician Public Health Fellow. She has medical qualifications in general surgery (Johns Hopkins) and ophthalmology (the Wilmer Institute, Johns Hopkins).

Fiona Fernandez

Job Titles:
  • Office Manager
  • Office Manager of Syncona Investment Management Ltd
Fiona is the Office Manager of Syncona Investment Management Ltd overseeing the daily operations of the office and supporting a number of the partners. Prior to joining Syncona, Fiona held various senior support roles, most recently as an Executive Assistant at AnaCap Financial Partners, supporting two of the Partners, Legal Counsel and the Mergers and Acquisitions team. Fiona holds a degree in Geography and Management from Leeds University.

Freddie Dear

Job Titles:
  • Partner of Syncona Investment Management Ltd

Gian Piero Reverberi

Job Titles:
  • Non - Executive Director
  • Senior Healthcare Executive
Gian Piero Reverberi is a senior healthcare executive and is presently Senior Vice President and Chief Commercial Officer at Vanda Pharmaceuticals, a specialty pharmaceutical company focused on novel therapies to address high-unmet medical needs. Prior to this, Gian Piero acted as a corporate adviser supporting companies in the development of their commercial and geographical expansion strategies. He also spent 10 years at Shire, where he served as Senior Vice President International Specialty Pharma, with responsibility for EMEA, Canada, Asia Pacific and Latin America. He started his pharmaceutical career at Eli Lilly in the US and Italy, where he had responsibilities including finance, business development, sales and business unit leadership. Experience Gian Piero has over 20 years of experience in commercialising novel therapies spanning commercial strategy, business development, business unit leadership and management, launching specialty and orphan drugs across international markets. He has a degree in Economics and Business Administration from Sapienza University of Rome and a Master in Business Administration from SDA Bocconi in Italy.

Hitesh Thakrar

Job Titles:
  • Partner of Syncona Investment Management Ltd
Hitesh is a Partner of Syncona Investment Management Ltd. He has 24 years' experience of global public equities. He managed Innovation funds for several asset management companies including Aviva and ADIA, where he was a top-rated portfolio manager. He has an interest in the convergence of life science with other innovationled sectors such as data sciences and the application of industrial technology in medical diagnostics. He has a degree in Chemistry from King's College London and is a CFA.

Jeremy Tigue - Chairman

Job Titles:
  • Chairman of the Board
  • Member of the Syncona Team
  • Nomination Committee ( Chair )
Jeremy Tigue has been Chairman of the Board since the Company's inception in 2012. He has over 30 years' experience of global investing and was the fund manager of Foreign & Colonial Investment Trust, one of the largest investment companies, from 1997 to 2014. He is also Chairman of ICG Enterprise Trust plc, Senior Independent Director of Aberdeen Standard Equity Income Trust PLC, a Director and Chairman of the Audit Committee of The Monks Investment Trust PLC and Senior Independent Director of The Mercantile Investment Trust plc. He was a Director of the Association of Investment Companies from 2003 to 2013 and Deputy Chairman between 2006 and 2010. Jeremy was also Chairman of the Institutional Shareholder Committee from 2006 to 2008. He was an Investment Advisor to the BP and British Steel Pension Funds from 1998 to 2014 and 1999 to 2014 respectively. Jeremy brings extensive experience of investments, private equity, investor relations and governance. He has broad and deep knowledge of all aspects of investment company management, governance and regulation.

John Bradshaw - CFO

Job Titles:
  • Chief Financial Officer
John Bradshaw is the Chief Financial Officer of Syncona Investment Management Ltd. He has worked extensively with companies in the life science sector as a part-time and interim CFO. He was previously CFO of Gyrus Group PLC and qualified as a chartered accountant with Arthur Andersen. John has a degree in Law from the University of Liverpool.

Katie Trafford

Job Titles:
  • Executive Assistant
Katie Trafford is Executive Assistant at Syncona Investment Management Limited. Prior to joining Syncona, Katie was a Personal Assistant to Finance Directors at Wellcome Trust. Katie has over five years financial PA experience after graduating from Oxford Media & Business School.

Magdalena Jonikas

Job Titles:
  • Partner of Syncona Investment Management Ltd
Magdalena is a Partner of Syncona Investment Management Ltd. Previously, she was an Associate Partner at McKinsey & Company where she specialised in pharmaceuticals Research & Development, portfolio management and Business Development and Licensing. Magdalena holds a PhD in Bioengineering from Stanford University and was a postdoctoral fellow in Harvard Medical School's Computational Health Informatics Programme.

Martin Murphy - CEO

Job Titles:
  • Chief Executive Officer
  • Member of the Syncona Team
  • Chief Executive Officer of Syncona Investment Management Ltd
Martin is Chief Executive Officer of Syncona Investment Management Ltd. He co-founded Syncona in 2012 with The Wellcome Trust. Since then, Martin has been closely involved in the foundation and development of four Syncona companies: Achilles, Autolus, Blue Earth and OMass Therapeutics and continues to hold Board positions at these companies. Previously, he was a partner at MVM Life Science Partners LLP, a venture capital company focused on life science and healthcare, where he led their European operations. Martin has also held roles with 3i Group plc and McKinsey & Company. He has a PhD in Biochemistry from the University of Cambridge.

Melanie Gee - Chairman

Job Titles:
  • Chairman
  • Non - Executive Director
Melanie Gee is Chair-designate and joined the Board in June 2019. Melanie has over 30 years financial advisory experience in executive positions in investment banking, advising clients across a broad range of sectors and geographies. Melanie also has extensive Non-Executive experience, having spent eight years in Non-Executive Director roles for three FTSE100 and 250 companies where she has served on numerous committees. She is a Senior Adviser at Lazard & Co Ltd, having joined as a managing director in 2008. Formerly, Melanie spent 25 years with SG Warburg & Co Ltd and then UBS. Melanie is a Non-Executive Director at Standard Life Aberdeen where she sits on the Nomination & Governance; Audit; and Risk and Capital Committees and is the Non-executive Director with responsibility for bringing the employee voice into the Boardroom. She was previously a Non-Executive Director at Standard Life plc, prior to its merger with Aberdeen Asset Management plc. Melanie was also a Non-Executive Director of The Weir Group PLC from April 2011 to September 2017 and of Drax Group PLC from January 2013 to April 2016. Melanie sits on an advisory group for a European family office and is Chairman of Ridgeway Partners Holdings Limited, a search firm. She was an alternate member of The Takeover Panel - LIBA (CFC) between 2006 and 2013

Michael Kyriakides

Job Titles:
  • Partner
  • Partner of Syncona Investment Management Ltd
Michael Kyriakides is a Partner of Syncona Investment Management Ltd Previously, Michael was a member of the Life Sciences team at L.E.K. Consulting, where he worked in projects for pharmaceutical, biotech and private equity clients. Prior to joining L.E.K. Consulting, he was a clinical project and NMR manager in the Faculty of Medicine at Imperial College London. Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.

Nick Moss

Job Titles:
  • Chartered Accountant
  • Senior Independent Director
  • Remuneration Committee ( Chair )
Nick Moss is an English qualified chartered accountant (FCA) and has nearly 30 years' experience in the financial services sector, focused primarily on the structuring, advising and administration of the overall wealth of ultra high net worth private clients. Nick was a founder of the Virtus Trust, an international fiduciary business which he sold to Equiom group in 2017. Prior to Virtus, Nick was a Managing Director within NM Rothschild's private wealth group. Experience Nick has extensive experience as an independent director and audit committee member of listed closed-ended investment companies including Brevan Howard and Blackstone managed entities. He is a highly experienced fiduciary and investment practitioner, advising family offices and private clients in many jurisdictions. Nick was Chairman of the Audit Committee of the Company until 31 March 2018 and became Senior Independent Director on 1 April 2018.

Nigel Keen

Job Titles:
  • Non - Executive Director
  • Chairman of Syncona Investment Management Limited
Nigel Keen is the Chairman of Syncona Investment Management Limited and was a co-founder of Syncona Partners. He is also Chairman of Oxford University Innovation, the technology transfer group for Oxford University, and Chairman of the Oxford Academic Health Science Network, an entity established by the National Health Service in England to align the interests of patients in its region with academia, industry and the healthcare system. He has recently been appointed to chair MedAccess, a newly established entity sponsored by DIFID to enable the provision of medicines to countries in sub-Saharan Africa and South Asia. Previously he was Chairman of Laird plc for 14 years and Oxford Instruments plc for 16 years. His career has encompassed venture capital, industry and banking. He has a degree in engineering from Cambridge University, is a Fellow of the Institute of Chartered Accountants, a Fellow of the Institute of Engineering and Technology and has been involved in the formation and development of high technology businesses for more than thirty years. He He is also the Chairman of the AIM listed medical device company, Deltex Medical Group plc. Experience Nigel brings extensive experience in healthcare and commerce. His career has encompassed venture capital, industry and banking, and he has been involved in the formation and development of high technology businesses for more than 30 years.

Nikki Padden - CFO

Job Titles:
  • Head of Finance
Nikki is Head of Finance at Syncona Investment Management Ltd She is a chartered accountant with experience in practice and commerce. Previous roles include business operations at GlaxoSmithKline and project management for AEA Technology and its biopharmaceutical contract manufacturing spin-out. Prior to this she worked in research at King's College, London and the University of Reading. Nikki has a PhD in Biotechnology from King's College and an MBA from Warwick Business School.

Nisha Sethi - Chief Legal Officer

Job Titles:
  • Legal Counsel
Nisha Sethi is the Legal Counsel at Syncona Investment Management Limited. Previously, Nisha worked as Legal Counsel for Animo Associates Limited, a corporate service provider specialising in compliance and management consulting advice. Prior to this, Nisha qualified at Noble Solicitors which is where she spent 5 years predominantly specialising in criminal defence law. Nisha holds an LLB from the University of Reading.

Rob Hutchinson

Job Titles:
  • Audit Committee ( Chair )
  • Non - Executive Director
Rob Hutchinson has around 30 years' experience in the financial sector as a Chartered Accountant. He qualified in 1990 and spent 28 years with KPMG across various roles. Rob retired from practice in 2014 and is a Fellow of the Institute of Chartered Accountants in England and Wales. He served as President of the Guernsey Society of Chartered and Certified Accountants between 2007 and 2009. Experience Rob has many years of broad financial experience. He spent a number of years in roles specialising in the audit of banking and fund clients at KPMG and was appointed a partner in 1999. Rob led the audits for a number of UK and European Private Equity and Venture Capital houses as well as listed funds covering a variety of asset classes, bringing broad experience in issues arising from the valuation of private assets. Rob led the firm's fund and private equity practices for seven years and served as Head of Audit for KPMG in the Channel Islands for five years until 2013.

Siobhan Weaver

Job Titles:
  • Head of Investor Relations and Communications
Siobhan Weaver is Head of Investor Relations and Communications at Syncona Investment Management Ltd. Previously, she worked at Tulchan Communications, a financial communications agency, where she was a Director providing advice to a range of clients across a wide range sectors, projects and transactions. Siobhan has spent seven years in financial communications, having previously worked for one of the leading consultancies in Australia. She has degrees in Law and Media Communications from the University of Melbourne.

Thomas Henderson

Job Titles:
  • Non - Executive Director, Chair of the Syncona Foundation
Thomas Henderson founded BACIT Ltd (now Syncona Limited) in 2012. Previously, Thomas founded New Generation Haldane Fund Management (formerly Eden Capital Ltd) in 1998 where he was CEO and senior portfolio manager for the Eden Capital Fund, a fund which had a mandate to invest in listed equity and private equity investments, primarily in Europe. Prior to this, in 1994 Thomas joined Moore Capital Management as a portfolio manager where he invested in European and emerging market equities. In 1991 Thomas worked for Cazenove Inc in New York and headed the European Equity sales team, where he was responsible for selling European equities to US institutions. He started his career in 1990 at Cazenove and Co in London. Experience Thomas brings extensive experience of managing capital in listed equities and in building private equity investments which have gone on to list in the US capital markets. He has a broad and deep network of relationships and a strong track record in the fund management industry. Thomas also sits on the investment committee at The Institute of Cancer Research.